Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Traded Jan 12, 2026 · Filed Jan 13, 2026
The CEO of AAR sold $2.93M of AAR shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,925,030
Shares × reported transaction price
6 days after results of Jan 6, 2026, 71 days before results of Mar 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.9% | −0.7% | +6.6% |
| 30 days | +11.8% | −1.3% | +13.0% |
| 90 days | +24.6% | +0.6% | +24.1% |
| 180 days | +29.5% | +8.5% | +21.0% |
Past results only. Not a forecast.
Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Traded Feb 4 · filed the same dayNot under a reported trading plan
The CFO of AAR sold $1.17M of AAR shares. The filing does not indicate a pre-arranged trading plan.
Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.